you will not believe your EYES!!! I just paid for the $200/month ChatGPT Operator Pro plan that and I couldn't believe what I was watching, so I recorded my screen to share with the world. This video ...

Dimerix Limited, a biopharmaceutical company with a phase 3 clinical asset in kidney disease, announces that the ACTION3 phase 3 trial of DMX-200 in patients with focal segmental glomerulosclerosis ...

MELBOURNE, Australia, Dec. 15, 2025 /PRNewswire/ -- Dimerix Limited (ASX: DXB), a biopharmaceutical company with a Phase 3 clinical asset in kidney disease, today announces that the ACTION3 Phase 3 ...

(RTTNews) - Dimerix Limited (DXB.AX) has completed adult patient enrolment in its pivotal ACTION3 Phase 3 trial of DMX-200 for focal segmental glomerulosclerosis, successfully dosing its 286th patient ...

Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial [1], which has recruited and dosed its target 286 th adult patient The ACTION3 Phase 3 trial explores the efficacy and ...

The ACTION3 trial opened 219 sites across 21 countries and regions, including the United States, Europe, United Kingdom, Japan, China, and Australia. Recruitment of pediatric patients continues as an ...